| Date Filed | Type | Description |
| 04/28/2023 |
4
| SHAH MAHENDRA (Director) has filed a Form 4 on Verona Pharma plc|
Txns:
| Granted 96,000 options to buy
@ $0 |
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| SHAH MAHENDRA (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.99, valued at
$49.8k
|
|
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2022 |
4
| SHAH MAHENDRA (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.03, valued at
$75.8k
|
|
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2021 |
4
| SHAH MAHENDRA (Director) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 11,500 options to buy
@ $9.96, valued at
$114.5k
|
|
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/18/2018 |
4
| SHAH MAHENDRA (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 15,931 options to buy
@ $2.04, valued at
$32.5k
|
|
| 05/16/2018 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/04/2018 |
4
| SHAH MAHENDRA (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Converted 659,742 shares
@ $0
Granted 500,000 shares
@ $16, valued at
$8M
Converted 659,742 preferred shares
@ $0 |
|
| 03/29/2018 |
4
| SHAH MAHENDRA (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 31,160 options to buy
@ $16, valued at
$498.6k
|
|
| 03/27/2018 |
3
| SHAH MAHENDRA (Director) has filed a Form 3 on Homology Medicines, Inc. |
| 02/07/2018 |
4
| SHAH MAHENDRA (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 3,466 shares
@ $1.7263, valued at
$6k
|
|
| 07/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/09/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |